Logo

Epoch to Supply MGB Eclipse Probe Systems for Millennium

Oct 14, 2003

NEW YORK, Oct. 14 (GenomeWeb News) - Epoch Biosciences said today that it has reached an agreement with Millennium Pharmaceuticals for its MGB Eclipse Probe Systems for multiplexed gene expression analysis.

Epoch said it would develop, functionally test, and supply multiplexed MGB Eclipse assays to gene targets specified by Millennium.

On Oct. 6, Epoch said it had terminated a distribution agreement for the MGB Eclipse Probe Systems with Amersham Biosciences.

Breaking News
The Scan

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.

TB Resistance Insights Gleaned From Genome Sequence, Antimicrobial Response Assays

Researchers in PLOS Biology explore M. tuberculosis resistance with a combination of sequencing and assays looking at the minimum inhibitory concentrations of 13 drugs.

Mendelian Disease Genes Prioritized Using Tissue-Specific Expression Clues

Mendelian gene candidates could be flagged for further functional analyses based on tissue-specific transcriptome and proteome profiles, a new Journal of Human Genetics paper says.

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.